UBS reiterates Starbucks stock rating ahead of earnings By Investing.com

UBS reiterated a Neutral rating on Starbucks with a $100 price target ahead of fiscal Q2 earnings on April 28, versus a current share price of $98.88. The firm expects U.S. same-store sales of 5% to 7%, above consensus at 3.9%, but still sees shares as fairly to fully valued given the company’s multi-year turnaround already reflected in the stock. Other analysts remain constructive overall, with price targets ranging from $105 to $122 and mixed views on the risk of an earnings miss, valuation, and the impact of the China transaction.

Analysis

The market is trying to price two different Starbucks stories at once: near-term traffic stabilization versus a longer-duration multiple reset. If U.S. comps come in at the high end of the expected range, the stock can squeeze higher on earnings because positioning is clearly crowded on the bearish side; but at ~80x earnings, even a clean beat is unlikely to re-rate the name materially unless management meaningfully lifts the 2026-2028 growth path. That creates a classic “good quarter, limited follow-through” setup.

Second-order, the China JV transition matters less as an earnings bridge than as a capital allocation signal. If the transaction lowers reported operating volatility, it may improve headline guidance quality, but it also removes a source of optionality that bulls previously used to justify premium valuation. Meanwhile, stronger U.S. promotions and menu innovation can support ticket and traffic, but they also risk compressing margins if the improvement is bought via discounting rather than structural demand recovery.

The most interesting tell is the divergence between analyst target dispersion and valuation discipline: the upside case is being framed as execution-driven, while the downside case is almost entirely multiple compression. That means the stock is vulnerable to any hint that traffic gains are being funded by lower unit economics, or that middle-income consumer softness is spreading into premium brands. In that scenario, the move lower could be fast because the name has less fundamental downside protection than the consensus implies.

Contrarian view: the consensus may be overestimating how much of a turnaround can be monetized into the current multiple. If management merely meets modest same-store-sales expectations without a decisive 2026 guidance raise, the stock likely trades on valuation gravity rather than operating momentum. The setup favors owning near-term event convexity, but not necessarily chasing the equity for a multi-quarter thesis from here.

Key Decisions for Investors

• Trade the event with a defined-risk long call spread into earnings: buy SBUX weekly or monthly upside calls and finance with a higher strike call sale, targeting a 3:1 payoff if comps and guidance both surprise positively; cut if the first post-print move fails to hold by the next session.
• If already long SBUX, trim 25-50% into the report and replace with a call spread; this preserves upside to a beat while reducing exposure to multiple compression if the quarter is merely in-line.
• Consider a relative-value short SBUX vs long DNKN/CMG-style premium consumer optionality only if the print shows traffic tied to discounting; the trade works best over 1-3 months if margin quality deteriorates faster than revenue growth.
• For bearish expression, use put spreads 5-10% below spot after any post-earnings spike; the risk/reward improves materially if management fails to raise fiscal 2026 guidance and the market refocuses on valuation.
• Set a tactical buy/cover trigger only on a sustained break above the highest analyst target cluster plus upward guidance revision; absent that, assume any rally is a trading move, not a fresh fundamental re-rating.